In fact, an amplification of the MYCN locus, which is located on chromosome 2p24, is present in approximately 20% of NB patients [7], and the degree of amplification is associated with advanced disease, unfavorable biologic features, and poor outcomes. The gene discussed is MYCN; the disease is neuroblastoma.